Cargando…
Correlation of antidepressant target dose optimization and achievement of glycemic control
INTRODUCTION: Depression is a recognized cause of disability globally with a propensity to be comorbid in patients with diabetes, leading to poorer health-related outcomes. Although a number of studies have investigated the correlation between improvement in depression and chronic disease, none have...
Autores principales: | Grisham-Takac, Catlin, Lai, Phillip, Srinivasa, Maaya, Vasquez, Lindsay, Rascati, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322821/ https://www.ncbi.nlm.nih.gov/pubmed/30627498 http://dx.doi.org/10.9740/mhc.2019.01.012 |
Ejemplares similares
-
Toward achieving optimal response: understanding and managing antidepressant side effects
por: Kelly, Karen, et al.
Publicado: (2008) -
Impact of age on optimal dose of antidepressants
por: Hashimoto, Kenji
Publicado: (2020) -
Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes
por: Ruelas, Valerie, et al.
Publicado: (2009) -
Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy
por: Kim-Romo, Dawn N., et al.
Publicado: (2016) -
Barriers to Achieving Glycemic Targets: Who Omits Insulin and Why?
por: Weinger, Katie, et al.
Publicado: (2010)